Eliem Therapeutics (ELYM) News Today → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free ELYM Stock Alerts $8.95 -0.37 (-3.97%) (As of 05/9/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineShort Interest in Eliem Therapeutics, Inc. (NASDAQ:ELYM) Increases By 4,453.8%marketbeat.com - April 25 at 10:48 AMBML Capital Management LLC Boosts Holdings in Eliem Therapeutics, Inc. (NASDAQ:ELYM)marketbeat.com - April 24 at 5:18 AMEliem Therapeutics (NASDAQ:ELYM) Trading 0.5% Higher marketbeat.com - April 23 at 2:35 AMSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Eliem Therapeutics, Inc. (ELYM) and Encourages Investors to Contact the Firmprnewswire.com - April 15 at 8:15 AMEliem Therapeutics, Inc.: Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placementfinanznachrichten.de - April 12 at 1:28 AMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALPN, ELYM, MODNstockhouse.com - April 11 at 3:23 PMEliem Therapeutics Shifts From Neurology With New Found Focus On Autoimmune Diseases With Tenet Medicines Dealfinance.yahoo.com - April 11 at 3:23 PMEnlivex Therapeutics, Nyxoah SA, China SXT Pharmaceuticals among healthcare moversmsn.com - April 11 at 10:23 AMEliem Therapeutics To Buy Tenet Medicines, Plans $120 Mln Private Placement; Stock Up In Pre-marketmarkets.businessinsider.com - April 11 at 10:23 AMELYM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Eliem Therapeutics, Inc. Is Fair to Shareholdersbusinesswire.com - April 11 at 8:30 AMEliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placementglobenewswire.com - April 11 at 7:00 AMELYM Stock Earnings: Eliem Therapeutics Reported Results for Q4 2023msn.com - April 5 at 8:03 AMHere's Why We're Not Too Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Situationfinance.yahoo.com - March 6 at 4:17 PMSilverarc Capital Management LLC Lowers Holdings in Eliem Therapeutics, Inc. (NASDAQ:ELYM)marketbeat.com - February 18 at 12:54 PMEliem Therapeutics (NASDAQ:ELYM) Shares Up 3.5%marketbeat.com - February 3 at 2:11 AMCheckpoint Therapeutics Inc CKPTmorningstar.com - November 19 at 9:35 AMEliem Therapeutics Inc ELYMmorningstar.com - November 15 at 8:05 PMEliem Therapeutics (NASDAQ:ELYM) Is In A Good Position To Deliver On Growth Plansfinance.yahoo.com - September 28 at 2:00 PMEliem (ELYM) to Explore Strategic Options, Stock Rises 6%finance.yahoo.com - July 21 at 12:26 PMEliem Therapeutics’ stock soars 21% premarket after company says it may sell itselfmsn.com - July 21 at 7:26 AMWhat's Happening With Eliem Therapeutics Shares Today?benzinga.com - July 20 at 3:37 PMEliem Therapeutics, Inc.: Eliem Therapeutics Announces Plans to Explore Strategic Alternativesfinanznachrichten.de - July 20 at 10:22 AMEliem Therapeutics Shares Rally Premarket on Exploration of Options >ELYMmarketwatch.com - July 20 at 10:22 AMWhy Is Eliem Therapeutics (ELYM) Stock Up 6% Today?markets.businessinsider.com - July 20 at 10:22 AMEliem Therapeutics Announces Plans to Explore Strategic Alternativesfinance.yahoo.com - July 20 at 10:22 AMStifel Nicolaus Sticks to Its Buy Rating for Eliem Therapeutics (ELYM)markets.businessinsider.com - June 7 at 2:29 AMStifel Nicolaus Reaffirms Their Buy Rating on Eliem Therapeutics (ELYM)markets.businessinsider.com - May 25 at 8:00 AMEliem Therapeutics, Inc.: Eliem Therapeutics Reports First Quarter Financial Results and Business Highlightsfinanznachrichten.de - May 12 at 10:15 AMEliem Therapeutics GAAP EPS of -$0.84seekingalpha.com - May 11 at 8:03 PMEliem Therapeutics Reports First Quarter Financial Results and Business Highlightsfinance.yahoo.com - May 11 at 8:03 PMmarketbeat.com - May 5 at 10:03 AMWe're Hopeful That Eliem Therapeutics (NASDAQ:ELYM) Will Use Its Cash Wiselyfinance.yahoo.com - April 21 at 4:15 PMSVB Securities Keeps Their Buy Rating on Eliem Therapeutics (ELYM)markets.businessinsider.com - March 9 at 3:05 AMEliem Therapeutics, Inc.: Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlightsfinanznachrichten.de - March 7 at 5:40 AMEliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlightsfinance.yahoo.com - March 6 at 7:39 PMELYM Eliem Therapeutics, Inc.seekingalpha.com - February 23 at 6:33 PMEliem Therapeutics slashing staff amid leadership shakeupfinance.yahoo.com - February 23 at 2:52 AMEliem Pauses Development On Depression Drug, Lays Off 55% Workforcefinance.yahoo.com - February 18 at 10:23 AMEliem Therapeutics down after announcing reprioritization plans, layoffsmsn.com - February 10 at 9:10 AMEliem Therapeutics Provides Strategic Update and Announces Leadership Transitionfinance.yahoo.com - February 9 at 6:06 PMmarketbeat.com - February 9 at 4:06 PMmarketbeat.com - February 6 at 9:51 AMEliem Therapeutics, Inc. (NASDAQ:ELYM) Short Interest Updatemarketbeat.com - January 27 at 5:20 PMEliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conferencefinance.yahoo.com - November 30 at 8:06 AMEliem Therapeutics, Inc.: Eliem Therapeutics Reports Third Quarter Financial and Business Highlightsfinanznachrichten.de - November 14 at 12:03 PMIs Eliem Therapeutics (NASDAQ:ELYM) In A Good Position To Invest In Growth?finance.yahoo.com - November 12 at 11:04 AMEliem Therapeutics to Participate at Two Upcoming Investor Conferencesfinance.yahoo.com - November 8 at 9:59 AMEliem Therapeutics (ELYM) Investor Presentation - Slideshowseekingalpha.com - August 18 at 6:51 PMEliem Therapeutics: Q2 Earnings Insightsmsn.com - August 15 at 11:56 AMEliem Therapeutics Reports Second Quarter Financial and Business Highlightsfinance.yahoo.com - August 15 at 11:56 AM Get Eliem Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ELYM and its competitors with MarketBeat's FREE daily newsletter. Email Address The “Next Bitcoin”? 10 CENT Crypto Set to Explode (Ad)The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 ELYM Media Mentions By Week ELYM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELYM News Sentiment▼0.000.43▲Average Medical News Sentiment ELYM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELYM Articles This Week▼00▲ELYM Articles Average Week Get Eliem Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ELYM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Telomir Pharmaceuticals News G1 Therapeutics News Veru News Lifecore Biomedical News Design Therapeutics News Zevra Therapeutics News Alimera Sciences News Trevi Therapeutics News Atossa Therapeutics News Generation Bio News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ELYM) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaObama’s Forever Term [exposed]Porter & CompanyThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders348 million Americans lives to END as we know it?The Oxford ClubUrgent Nvidia WarningAltimetryRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eliem Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
